{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:18:51Z","timestamp":1788355131359,"version":"build-2803163510"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Metastasis is the main cause of cancer-related death worldwide. Thus, significant efforts have been directed towards inhibiting metastasis to avoid regrowth or relapse after cytostatic and\/or cytotoxic cancer treatments. Drugs targeting cell-invasiveness are known as migrastatics and primarily target the cytoskeleton to impair cell motility and\/or invasive mechanisms. However, the cytoskeleton is essential to perform many fundamental processes, including cell division. Consequently, migrastatics often prompt high toxicity, among other serious side effects, which have prevented their clinical use to this date. In this review, we present the current migrastatics scenario, including their main limitations, and discuss proposed alternatives.<\/jats:p>","DOI":"10.3389\/fonc.2026.1907560","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:37:10Z","timestamp":1788352630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Migrastatics: an overview of the current scenario and future cancer treatments"],"prefix":"10.3389","volume":"16","author":[{"given":"Irene","family":"Olivas-Cano","sequence":"first","affiliation":[{"name":"Cytoskeletal Dynamics in Cell Migration and Cancer Invasion Lab, Department of Cancer, Centro de Investigaci\u00f3n Pr\u00edncipe Felipe (CIPF)","place":["Valencia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Angeles","family":"Juanes","sequence":"additional","affiliation":[{"name":"Cytoskeletal Dynamics in Cell Migration and Cancer Invasion Lab, Department of Cancer, Centro de Investigaci\u00f3n Pr\u00edncipe Felipe (CIPF)","place":["Valencia, Spain"]},{"name":"School of Health and Life Science, Teesside University","place":["Middlesbrough, United Kingdom"]},{"name":"National Horizons Centre, Teesside University","place":["Darlington, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s12032-025-03072-x","article-title":"Cancer metastasis: therapeutic challenges and opportunities","volume":"42","author":"Garemilla","year":"2025","journal-title":"Med Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.trecan.2017.04.008","article-title":"Migrastatics\u2014anti-metastatic and anti-invasion drugs: promises and challenges","volume":"3","author":"Gandalovi\u010dov\u00e1","year":"2017","journal-title":"Trends Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0010","article-title":"Metastasis initiating cells and ecosystems","volume":"11","author":"Massagu\u00e9","year":"2021","journal-title":"Cancer Discov"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E25-08-0396","article-title":"Dissecting cytoskeletal crosstalk through reconstituted actin\u2013microtubule systems","volume":"37","author":"Chowdhury","year":"2026","journal-title":"Mol Biol Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00508-4","article-title":"Biochemical and mechanical regulation of actin dynamics","volume":"23","author":"Lappalainen","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202309021","article-title":"Mechanisms of actin disassembly and turnover","volume":"222","author":"Goode","year":"2023","journal-title":"J Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2024.102419","article-title":"Actin filament dynamics at barbed ends: new structures, new insights","volume":"90","author":"Courtemanche","year":"2024","journal-title":"Curr Opin Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-025-01608-9","article-title":"Roles of cytoskeleton in metastasis: from its mechanism to therapeutic strategies","volume":"58","author":"Lim","year":"2026","journal-title":"Exp Mol Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-025-56299-7","article-title":"Matrix mechano-sensing at the invasive front induces a cytoskeletal and transcriptional memory supporting metastasis","volume":"16","author":"Maiques","year":"2025","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030578","article-title":"Early events in actin cytoskeleton dynamics and E-cadherin-mediated cell-cell adhesion during epithelial-mesenchymal transition","volume":"9","author":"Zhitnyak","year":"2020","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041821","article-title":"Phenotypic plasticity of cancer cells based on remodeling of the actin cytoskeleton and adhesive structures","volume":"22","author":"Rubtsova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","article-title":"Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies","volume":"23","author":"Hao","year":"2025","journal-title":"J Transl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21923","article-title":"Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes","volume":"105","author":"Hakulinen","year":"2008","journal-title":"J Cell Biochem"},{"key":"B16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00018-009-0132-1","article-title":"The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells","volume":"67","author":"Pankov\u00e1","year":"2010","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4161\/sgtp.29846","article-title":"Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions","volume":"5","author":"Julian","year":"2014","journal-title":"Small GTPases"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0172-9","article-title":"Mechanisms of 3D cell migration","volume":"20","author":"Yamada","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.07.050","article-title":"Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis","volume":"8","author":"Leong","year":"2014","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15146","article-title":"Notch-1 signaling promotes reattachment of suspended cancer cells by cdc42-dependent microtentacles formation","volume":"112","author":"Li","year":"2021","journal-title":"Cancer Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3628","article-title":"Crossing the endothelial barrier during metastasis","volume":"13","author":"Reymond","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.259586","article-title":"Fluid shear stress regulates the survival of circulating tumor cells via nuclear expansion","volume":"135","author":"Xu","year":"2022","journal-title":"J Cell Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081845","article-title":"Are we ready for migrastatics","volume":"10","author":"Solomon","year":"2021","journal-title":"Cells"},{"key":"B24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.trecan.2023.01.001","article-title":"Engine shutdown: migrastatic strategies and prevention of metastases","volume":"9","author":"Raudensk\u00e1","year":"2023","journal-title":"Trends Cancer"},{"key":"B25","unstructured":"Migrastatic  therapy as a potential game-changer  in adaptive cancer treatment\n          \n          \n            \n              Schneider\n              K\n            \n            \n              Spekking\n              L\n            \n            \n              Azimi\n              S\n            \n            \n              Peltanov\u00e1\n              B\n            \n            \n              R\u00f6sel\n              D\n            \n            \n              Brown\n              JS\n            \n          \n          10.1038\/s41598-025-33902-x\n          Sci Rep\n          \n          2026"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.04.003","article-title":"Educate, not kill: treating cancer without triggering its defenses","volume":"30","author":"\u0160karkov\u00e1","year":"2024","journal-title":"Trends Mol Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-018-9914-x","article-title":"Editorial: therapy-induced metastasis","volume":"35","author":"Martin","year":"2018","journal-title":"Clin Exp Metastasis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910756","article-title":"Association of granulocyte colony-stimulating factor treatment with risk of brain metastasis in advanced stage breast cancer","volume":"25","author":"Tai","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(00)00420-x","article-title":"A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)","volume":"47","author":"Choy","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18050971","article-title":"Zampanolide, a microtubule-stabilizing agent, is active in resistant cancer cells and inhibits cell migration","volume":"18","author":"Field","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27134244","article-title":"In vivo evaluation of (-)-zampanolide demonstrates potent and persistent antitumor efficacy when targeted to the tumor site","volume":"27","author":"Takahashi-Ruiz","year":"2022","journal-title":"Molecules"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2020.151075","article-title":"Microtubule-targeting agents and their impact on cancer treatment","volume":"99","author":"\u010cerm\u00e1k","year":"2020","journal-title":"Eur J Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225650","article-title":"Microtubule targeting agents in disease: classic drugs, novel roles","volume":"13","author":"Wordeman","year":"2021","journal-title":"Cancers"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30163314","article-title":"Recent advances in microtubule targeting agents for cancer therapy","volume":"30","author":"Assun\u00e7\u00e3o","year":"2025","journal-title":"Molecules"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1039\/b908595e","article-title":"Spontaneous migration of cancer cells under conditions of mechanical confinement","volume":"1","author":"Irimia","year":"2009","journal-title":"Integr Biol Quant Biosci Nano Macro"},{"key":"B36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12906-021-03299-x","article-title":"Vincetoxicum arnottianum modulates motility features and metastatic marker expression in pediatric rhabdomyosarcoma by stabilizing the actin cytoskeleton","volume":"21","author":"Adamus","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2023.107228","article-title":"Bj-PRO-10c, as an allosteric regulator of argininosuccinate synthase, is a potential therapy for neuroblastoma metastasis","volume":"233","author":"Coutinho","year":"2023","journal-title":"Toxicon"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108862","article-title":"Design and synthesis of ROCK2-selective inhibitors bearing 6-indazolamino-2-pyrrolidinylpyridine for the treatment of breast cancer metastasis","volume":"164","author":"Zhang","year":"2025","journal-title":"Bioorganic Chem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2156","article-title":"Rho kinase inhibitors block melanoma cell migration and inhibit metastasis","volume":"75","author":"Sadok","year":"2015","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.83.3.657","article-title":"Cytochalasin inhibits the rate of elongation of actin filament fragments","volume":"83","author":"Brown","year":"1979","journal-title":"J Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(80)90619-4","article-title":"Mechanism of action of cytochalasin B on actin","volume":"20","author":"MacLean-Fletcher","year":"1980","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.102.1.282","article-title":"Cytochalasin B slows but does not prevent monomer addition at the barbed end of the actin filament","volume":"102","author":"Bonder","year":"1986","journal-title":"J Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.105.4.1473","article-title":"Effects of cytochalasin and phalloidin on actin","volume":"105","author":"Cooper","year":"1987","journal-title":"J Cell Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118502","article-title":"The potential of cytochalasins and other cytochalasans as drugs targeting cancer cell invasiveness and metastasis","volume":"304","author":"Bro\u017e","year":"2026","journal-title":"Eur J Med Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2423","article-title":"Cytochalasin D promotes pulmonary metastasis of B16 melanoma through expression of tissue factor","volume":"30","author":"Huang","year":"2013","journal-title":"Oncol Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26147021","article-title":"Cytochalasins suppress 3D migration of ECM-embedded tumoroids at non-toxic concentrations","volume":"26","author":"Beslm\u00fcller","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202410861","article-title":"NQO1-responsive prodrug for in cellulo release of cytochalasin B as cancer cell-targeted migrastatic","volume":"22","author":"Kagho","year":"2026","journal-title":"Small"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100844","article-title":"Immune cell migration to cancer","volume":"13","author":"Ryan","year":"2024","journal-title":"Cells"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09202-9","article-title":"Rescuing dendritic cell interstitial motility sustains antitumour immunity","volume":"645","author":"Tang","year":"2025","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.trecan.2017.09.006","article-title":"Migrating into the tumor: a roadmap for T cells","volume":"3","author":"Woude","year":"2017","journal-title":"Trends Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2025.05.006","article-title":"The role of the immune tumor microenvironment in shaping metastatic dissemination, dormancy, and outgrowth","volume":"36","author":"Grant","year":"2026","journal-title":"Trends Cell Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12967-023-03954-6","article-title":"Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1\/2 signaling","volume":"21","author":"Chill\u00e0","year":"2023","journal-title":"J Transl Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/21541248.2016.1224399","article-title":"Rac1 and RhoA: Networks, loops and bistability","volume":"9","author":"Nguyen","year":"2016","journal-title":"Small GTPases"},{"key":"B54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cels.2016.01.003","article-title":"Bistability in the Rac1, PAK, and RhoA signaling network drives actin cytoskeleton dynamics and cell motility switches","volume":"2","author":"Byrne","year":"2016","journal-title":"Cell Syst"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0012","article-title":"FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer","volume":"20","author":"Amiri-Kordestani","year":"2014","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1021\/acs.inorgchem.5c00813","article-title":"Cyclodextrin-based metal\u2013organic framework as an application platform for bioactive ruthenium(III) complexes","volume":"64","author":"Marzabad","year":"2025","journal-title":"Inorg Chem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-014-1207-5","article-title":"Translation in solid cancer: are size\u2010based response criteria an anachronism","volume":"17","author":"Fernandes","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S45177","article-title":"Drugs for solid cancer: the productivity crisis prompts a rethink","volume":"6","author":"R\u00f6sel","year":"2013","journal-title":"OncoTargets Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41416-021-01442-6","article-title":"A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma","volume":"125","author":"Maiques","year":"2021","journal-title":"Br J Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2026.102947","article-title":"Enhanced paclitaxel oral delivery by astragalus polysaccharide-based nanoplatform for triple-negative breast cancer treatment","volume":"74","author":"Nie","year":"2026","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.896994","article-title":"Synthesis, screening and characterization of novel potent Arp2\/3 inhibitory compounds analogous to CK-666","volume":"13","author":"Fokin","year":"2022","journal-title":"Front Pharmacol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00201-x","article-title":"CK-666 and CK-869 differentially inhibit Arp2\/3 iso-complexes","volume":"25","author":"Cao","year":"2024","journal-title":"EMBO Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2009.10.006","article-title":"Identification and characterization of a small molecule inhibitor of formin-mediated actin assembly","volume":"16","author":"Rizvi","year":"2009","journal-title":"Chem Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"9058","DOI":"10.3390\/ijms24109058","article-title":"Investigating mammalian formins with SMIFH2 fifteen years in: novel targets and unexpected biology","volume":"24","author":"Innocenti","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B65","first-page":"164","volume-title":"Vimentin Cytoskeleton Collapses Inresponse to the Small Moleculeinhibitor of FH2 Domains (SMIFH2)-Inducedelectrophilic Stress","author":"Capella","year":"2026"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201001016","article-title":"Adenomatous polyposis coli protein nucleates actin assembly and synergizes with the formin mDia1","volume":"189","author":"Okada","year":"2010","journal-title":"J Cell Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201702007","article-title":"Adenomatous polyposis coli nucleates actin assembly to drive cell migration and microtubule-induced focal adhesion turnover","volume":"216","author":"Juanes","year":"2017","journal-title":"J Cell Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123811","article-title":"Cytoskeletal control and Wnt signaling\u2014APC\u2019s dual contributions in stem cell division and colorectal cancer","volume":"12","author":"Juanes","year":"2020","journal-title":"Cancers"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106583","article-title":"APC-driven actin nucleation powers collective cell dynamics in colorectal cancer cells","volume":"26","author":"Baro","year":"2023","journal-title":"iScience"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109687","article-title":"Tumor invasiveness is regulated by the concerted function of APC, formins, and Arp2\/3 complex","volume":"27","author":"Baro","year":"2024","journal-title":"iScience"},{"key":"B71","doi-asserted-by":"publisher","first-page":"361ra140","DOI":"10.1126\/scitranslmed.aaf8127","article-title":"Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer","volume":"8","author":"Zhang","year":"2016","journal-title":"Sci Transl Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0887","article-title":"Cholesterol depletion by TASIN-1 induces apoptotic cell death through the ER stress\/ROS\/JNK signaling in colon cancer cells","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25020362","article-title":"New zampanolide mimics: design, synthesis, and antiproliferative evaluation","volume":"25","author":"Chen","year":"2020","journal-title":"Molecules"},{"key":"B74","unstructured":""},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.298","article-title":"Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro","volume":"75","author":"Terzis","year":"1997","journal-title":"Br J Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700444RR","article-title":"EB1 and cytoplasmic dynein mediate protrusion dynamics for efficient 3-dimensional cell migration","volume":"32","author":"Jayatilaka","year":"2018","journal-title":"FASEB J"},{"key":"B77","unstructured":""},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2011.08.001","article-title":"Docetaxel combined with targeted therapies in metastatic breast cancer","volume":"38","author":"Cortes","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"B79","unstructured":"FDA approves belumosudil for chronic GVHD - NCI\n          \n          \n            \n              Jaber\n              N\n            \n          \n          Cgvblogpost\n          \n          2021"},{"key":"B80","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1039\/D4NP00076E","article-title":"The cytochalasans: potent fungal natural products with application from bench to bedside","volume":"42","author":"Tammam","year":"2025","journal-title":"Nat Prod Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1039\/d4ob00634h","article-title":"Synthesis of cytochalasan analogues with aryl substituents at position 10","volume":"22","author":"Javorsk\u00e1","year":"2024","journal-title":"Org Biomol Chem"},{"key":"B82","article-title":"Performance of a label-free image-based 2D scratch wound healing assay to monitor cell migration and its inhibition","author":"Rieger","year":""},{"key":"B83","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1016\/j.cub.2025.08.023","article-title":"Differential interference with actin-binding protein function by acute cytochalasin B","volume":"35","author":"Lambert","year":"2025","journal-title":"Curr Biol CB"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5c00629","article-title":"Design and synthesis of actin-targeting 10-phenoxy cytochalasan analogues: balancing cytotoxicity and migrastatic activity","volume":"17","author":"Javorsk\u00e1","year":"2026","journal-title":"ACS Med Chem Lett"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1907560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:37:15Z","timestamp":1788352635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1907560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":84,"alternative-id":["10.3389\/fonc.2026.1907560"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1907560","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"article-number":"1907560"}}